Showing results (461-470 of 539) with videos related to

Sort By:
Pageof 54
Cancer Research|September 1, 1995
Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivativesT M Behr, R M Sharkey, M E Juweid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 16, 2013
Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibodyCatharina M van Rij, Susanne Lütje, Cathelijne Frielink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 26, 2011
Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibodyCatharina M van Rij, Robert M Sharkey, David M Goldenberg, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 27, 2022
Disrupting the Balance of Protein Quality Control Protein UBQLN2 Accelerates Tau ProteinopathyJulia E Gerson, Stephanie Sandoval-Pistorius, Jacqueline P Welday, et al.
Frontiers in Immunology|December 17, 2024
Kir6.1, a component of an ATP-sensitive potassium channel, regulates natural killer cell developmentNatalie Samper, Lilja Hardardottir, Delphine M Depierreux, et al.
Rehabilitation Psychology|March 9, 2023
Parent psychosocial adjustment to inpatient pediatric rehabilitation, and the role of uncertainty and self-careDana M Bakula, Katherine A Traino, Taylor M Dattilo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptideWilliam J McBride, Pat Zanzonico, Robert M Sharkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2011
Treatment of advanced pancreatic carcinoma with 90Y-Clivatuzumab Tetraxetan: a phase I single-dose escalation trialSeza A Gulec, Steven J Cohen, Kenneth L Pennington, et al.
Cancer Research|September 26, 2014
Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancerSusanne Lütje, Mark Rijpkema, David M Goldenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human TrialCaroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, et al.
Pageof 54